Cargando…
Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors
Glioblastoma (GBM) represents the most common and aggressive malignant primary brain tumors in adults. Response to standard treatment is transitory and the survival of clinical trial cohorts are little more than 14 months. GBM are characterized by excessive proliferation, invasiveness, and radio-/ch...
Autores principales: | Roy, Laurent-Olivier, Poirier, Marie-Belle, Fortin, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979513/ https://www.ncbi.nlm.nih.gov/pubmed/29642484 http://dx.doi.org/10.3390/ijms19041113 |
Ejemplares similares
-
Transforming growth factor beta isoforms in breast cancer.
por: Benson, J. R., et al.
Publicado: (1994) -
Expression of transforming growth factor beta mRNA isoforms in human breast cancer.
por: MacCallum, J., et al.
Publicado: (1994) -
Expressions and significances of CTSL, the target of COVID‐19 on GBM
por: Dong, Qiang, et al.
Publicado: (2021) -
Transformation of membranous into anti-GBM nephritis
por: Imtiaz, S., et al.
Publicado: (2012) -
Differential expression of transforming growth factor-β isoforms in bullous keratopathy corneas
por: Strzalka-Mrozik, Barbara, et al.
Publicado: (2010)